GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelluna ASA (OSTO:ULTIo) » Definitions » Policy Acquisition Expense

Zelluna ASA (OSTO:ULTIO) Policy Acquisition Expense


View and export this data going back to 2019. Start your Free Trial

What is Zelluna ASA Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Zelluna ASA Business Description

Industry
Traded in Other Exchanges
Address
Ullernchausseen 64, Oslo, NOR, 0379
Zelluna ASA is a clinical-stage biotechnology company developing novel immunotherapies against cancer and the development of T-Cell Receptor Natural Killer cell therapies for the treatment of solid cancers. The company's current pipeline consists of allogeneic TCR-NK R&D programs ZI-MA4-1, ZI-KL1-1, and ZI-PR-1 targeting well validated antigens expressed across a broad range of solid tumors.